Cargando…

Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma

Detalles Bibliográficos
Autores principales:	Costa, Caterina, Indovina, Paola, Mattioli, Eliseo, Forte, Iris Maria, Iannuzzi, Carmelina Antonella, Luzzi, Luca, Bellan, Cristiana, De Summa, Simona, Bucci, Enrico, Di Marzo, Domenico, De Feo, Marisa, Mutti, Luciano, Pentimalli, Francesca, Giordano, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567790/ https://www.ncbi.nlm.nih.gov/pubmed/33067416 http://dx.doi.org/10.1038/s41419-020-03016-5

Ejemplares similares

P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma
por: Costa, Caterina, et al.
Publicado: (2020)

Targeting SRC Family Kinases in Mesothelioma: Time to Upgrade
por: Indovina, Paola, et al.
Publicado: (2020)

Pharmacological Inhibition of WEE1 Potentiates the Antitumoral Effect of the dl922-947 Oncolytic Virus in Malignant Mesothelioma Cell Lines
por: Iannuzzi, Carmelina Antonella, et al.
Publicado: (2020)

The Oncolytic Virus dl922-947 Triggers Immunogenic Cell Death in Mesothelioma and Reduces Xenograft Growth
por: Di Somma, Sarah, et al.
Publicado: (2019)

The Oncolytic Caprine Herpesvirus 1 (CpHV-1) Induces Apoptosis and Synergizes with Cisplatin in Mesothelioma Cell Lines: A New Potential Virotherapy Approach
por: Forte, Iris Maria, et al.
Publicado: (2021)

PRMT5 silencing selectively affects MTAP‐deleted mesothelioma: In vitro evidence of a novel promising approach
por: Barbarino, Marcella, et al.
Publicado: (2020)

RBL1/p107 Expression Levels Are Modulated by Multiple Signaling Pathways
por: Ventura, Elisa, et al.
Publicado: (2021)

Intratumor microbiota as a novel potential prognostic indicator in mesothelioma
por: Pentimalli, Francesca, et al.
Publicado: (2023)

SRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiation
por: Casini, Nadia, et al.
Publicado: (2015)

Comparison of 3 Randomized Clinical Trials of Frontline Therapies for Malignant Pleural Mesothelioma
por: Meirson, Tomer, et al.
Publicado: (2022)

HUR protects NONO from degradation by mir320, which is induced by p53 upon UV irradiation
por: Alfano, Luigi, et al.
Publicado: (2016)

Mesothelioma Malignancy and the Microenvironment: Molecular Mechanisms
por: Cersosimo, Francesca, et al.
Publicado: (2021)

RB1 dual role in proliferation and apoptosis: Cell fate control and implications for cancer therapy
por: Indovina, Paola, et al.
Publicado: (2015)

Analysis of new treatments proposed for malignant pleural mesothelioma raises concerns about the conduction of clinical trials in oncology
por: Meirson, Tomer, et al.
Publicado: (2022)

CSF1/CSF1R Axis Blockade Limits Mesothelioma and Enhances Efficiency of Anti-PDL1 Immunotherapy
por: Magkouta, Sophia Fotiou, et al.
Publicado: (2021)

Synthesis of Novel Peptide Dendrimers PDL-GB2 and PDL-G2
por: Yunzhu, Lin, et al.
Publicado: (2015)

Analysis of Primary Cilium Expression and Hedgehog Pathway Activation in Mesothelioma Throws Back Its Complex Biology
por: Barbarino, Marcella, et al.
Publicado: (2022)

A Drug Screening Revealed Novel Potential Agents against Malignant Pleural Mesothelioma
por: Dell’Anno, Irene, et al.
Publicado: (2022)

BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment
por: Guazzelli, Alice, et al.
Publicado: (2019)

Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma
por: Porta, Camillo, et al.
Publicado: (2008)

MicroRNA-29b-1 impairs in vitro cell proliferation, self-renewal and chemoresistance of human osteosarcoma 3AB-OS cancer stem cells
por: DI FIORE, RICCARDO, et al.
Publicado: (2014)

Identification of PDL1-Related Biomarkers to Select Lung Adenocarcinoma Patients for PD1/PDL1 Inhibitors
por: Wu, Yanping, et al.
Publicado: (2020)

HLA-B*44 and C*01 Prevalence Correlates with Covid19 Spreading across Italy
por: Correale, Pierpaolo, et al.
Publicado: (2020)

Coronavirus Disease (Covid-19): What Are We Learning in a Country With High Mortality Rate?
por: Mutti, Luciano, et al.
Publicado: (2020)

Identification of candidate genes and prognostic value analysis in patients with PDL1-positive and PDL1-negative lung adenocarcinoma
por: Qi, Xiaoguang, et al.
Publicado: (2020)

A Glimpse in the Future of Malignant Mesothelioma Treatment
por: Pezzicoli, Gaetano, et al.
Publicado: (2021)

Immunotherapy for mesothelioma: a critical review of current clinical trials and future perspectives
por: Gray, Steven G., et al.
Publicado: (2020)

Identification of Overexpressed Genes in Malignant Pleural Mesothelioma
por: Morani, Federica, et al.
Publicado: (2021)

Is There Already a Need of Reckoning on Cancer Immunotherapy?
por: Correale, Pierpaolo, et al.
Publicado: (2021)

Geant 3.20
por: CERN. Geneva. Audiovisual Unit
Publicado: (1991)

Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive through NK cell effects
por: Bai, Haiyan, et al.
Publicado: (2023)

KRAS Mutations Are Associated with Shortened Survival in Patients with Epithelioid Malignant Pleural Mesothelioma
por: Vannucchi, Margherita, et al.
Publicado: (2023)

Retroviral Replicating Vector Delivery of miR-PDL1 Inhibits Immune Checkpoint PDL1 and Enhances Immune Responses In Vitro
por: Lin, Amy H., et al.
Publicado: (2017)

Switching off malignant mesothelioma: exploiting the hypoxic microenvironment
por: Nabavi, Noushin, et al.
Publicado: (2016)

Prognostic value of PDL1 expression in pancreatic cancer
por: Birnbaum, David J., et al.
Publicado: (2016)

PDL1 Expression on Plasma and Dendritic Cells in Myeloma Bone Marrow Suggests Benefit of Targeted anti PD1-PDL1 Therapy
por: Sponaas, Anne-Marit, et al.
Publicado: (2015)

Anlotinib Benefits the αPDL1 Immunotherapy by Activating ROS/JNK/AP-1 Pathway to Upregulate PDL1 Expression in Colorectal Cancer
por: Luo, Bixian, et al.
Publicado: (2022)

In vitro and in vivo characterization of highly purified Human Mesothelioma derived cells
por: Melotti, Alice, et al.
Publicado: (2010)

New Immunohistochemical Markers for Pleural Mesothelioma Subtyping
por: Di Stefano, Iosè, et al.
Publicado: (2023)

Prognostic and predictive value of PDL1 expression in breast cancer
por: Sabatier, Renaud, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_dq3h10sm7k0uak6e32ecoi7363